Ruth E. Pakyz

Multisite Investigation of Outcomes With Implementation of CYP2C19 Genotype-Guided Antiplatelet Therapy After Percutaneous Coronary Intervention

Larisa H. Cavallari, Craig R. Lee, Amber L. Beitelshees et al. · JACC: Cardiovascular Interventions · 2017 · 310 citations

Medicine, Cardiology, Pharmacology +16

The genetic response to short-term interventions affecting cardiovascular function: Rationale and design of the Heredity and Phenotype Intervention (HAPI) Heart Study

Braxton D. Mitchell, Patrick F. McArdle, Haiqing Shen et al. · American Heart Journal · 2008 · 119 citations · Full text

Medicine, Cardiology, Genetics +10

Pharmacogenomic polygenic response score predicts ischaemic events and cardiovascular mortality in clopidogrel-treated patients

Joshua P. Lewis, Joshua Backman, Jean‐Luc Reny et al. · European Heart Journal - Cardiovascular Pharmacotherapy · 2019 · 101 citations · Full text

Medicine, Cardiology, Pharmacology +17

Implementation of pharmacogenetics: The University of Maryland personalized anti‐platelet pharmacogenetics program

Alan R. Shuldiner, Kathleen Palmer, Ruth E. Pakyz et al. · American Journal of Medical Genetics Part C Seminars in Medical Genetics · 2014 · 97 citations · Full text

Medicine, Genetics, Pharmacology +14

The relation between CYP2C19 genotype and phenotype in stented patients on maintenance dual antiplatelet therapy

Paul A. Gurbel, Alan R. Shuldiner, Kevin P. Bliden et al. · American Heart Journal · 2011 · 92 citations

Medicine, Cardiology, Clinical Pharmacokinetics +15